• $34.7M
    Market Cap
  • 76.29%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
03/31/2025
03/31/2024
01/31/2024
01/31/2022
Income Statement
Total Operating Revenue
30.1M
N/A
N/A
N/A
28.3M
-21.71%
36.1M
0.00%
Cost of Revenue
17.6M
N/A
N/A
N/A
17.1M
-10.06%
19.1M
0.00%
Gross Profit
12.6M
N/A
0
-100.00%
11.1M
-40.22%
18.7M
0.00%
Sales and Marketing Expense
11.3M
N/A
N/A
N/A
9.7M
+5,713.19%
166,479
0.00%
Research and Development Expense
-19,071
N/A
N/A
N/A
-16,523
-38.30%
-26,781
N/A
Depreciation and Amortization Expense
1.7M
N/A
N/A
N/A
1.4M
-58.26%
3.4M
0.00%
Total Operating Expenses
11.3M
N/A
N/A
N/A
9.7M
+38.81%
7.0M
0.00%
Operating Profit
1.3M
N/A
N/A
N/A
1.5M
-80.43%
7.5M
0.00%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-293,675
N/A
N/A
N/A
-35,210
-99.15%
-4.1M
0.00%
Interest Income and Expense and Net
-293,675
N/A
0
+100.00%
-35,210
-99.15%
-4.1M
0.00%
Total Nonoperating Income and Expense
293,675
N/A
N/A
N/A
35,210
-99.15%
4.1M
0.00%
Income before Taxes
394,921
N/A
N/A
N/A
258,657
+104.24%
-6.1M
0.00%
Income Taxes
4.2M
N/A
N/A
N/A
3.5M
+47.17%
2.4M
0.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-4.0M
N/A
N/A
N/A
-3.3M
-45.87%
-6.1M
0.00%
Net Income from Continuing Operations Applicable to Common
-3.8M
N/A
N/A
N/A
-3.2M
-47.21%
-6.1M
0.00%
Basic EPS and Net Income
-0.03
N/A
N/A
N/A
-0.03
-133.33%
0.09
N/A
Diluted EPS and Net Income
-0.03
N/A
N/A
N/A
-0.03
-50.00%
-0.06
0.00%
Basic Weighted Average Shares
119.8M
N/A
N/A
N/A
120.0M
+14.50%
104.8M
0.00%
Diluted Weighted Average Shares
120.6M
N/A
N/A
N/A
122.9M
+17.21%
104.8M
0.00%
Balance Sheet
Cash and Cash Equivalents
2.6M
-19.48%
3.3M
+35.38%
2.4M
-61.38%
6.2M
0.00%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.6M
-19.48%
3.3M
+35.38%
2.4M
-61.38%
6.2M
0.00%
Total Current Assets
7.5M
-7.79%
8.1M
+12.37%
7.2M
-53.52%
15.6M
0.00%
Accumulated Depreciation
2.2M
+13.13%
2.0M
+5.03%
1.9M
+80.52%
1.0M
N/A
Property and Plant and Equipment and Net
2.7M
-21.39%
3.4M
-1.23%
3.4M
-12.35%
3.9M
0.00%
Total Long-Term Assets
2.7M
-21.39%
3.4M
-1.23%
3.4M
+25,208.47%
13,565
0.00%
Total Assets
57.0M
+3.21%
55.2M
+1.28%
54.5M
-20.75%
68.8M
0.00%
Income Taxes Payable
2.8M
-72.30%
10.2M
+5.25%
9.7M
+165.70%
3.7M
N/A
Total Short-Term Debt
2.1M
+84.57%
1.2M
0.00%
1.2M
+1,326.71%
81,044
0.00%
Total Current Liabilities
8.0M
-47.12%
15.0M
+6.23%
14.2M
-9.92%
15.7M
0.00%
Total Long-Term Debt
710,367
N/A
0
N/A
0
-100.00%
2.0M
N/A
Total Long-Term Liabilities
9.8M
+6.45%
9.2M
-1.03%
9.3M
-22.41%
12.0M
N/A
Total Liabilities
28.3M
+16.79%
24.3M
+3.28%
23.5M
-45.98%
43.5M
0.00%
Retained Earnings
-76.8M
+5.45%
-72.9M
+0.10%
-72.8M
-5.01%
-76.6M
0.00%
Total Stockholders Equity
28.7M
-7.42%
31.0M
-0.24%
31.0M
+22.53%
25.3M
0.00%
Total Shares Outstanding
118.0M
-1.71%
120.0M
0.00%
120.0M
+2.55%
117.1M
0.00%
Cash Flow
Cash from Operating Activities
1.2M
N/A
N/A
N/A
3.3M
-66.45%
9.9M
0.00%
Capital Expenditures
406,733
N/A
N/A
N/A
521,579
-79.64%
2.6M
N/A
Cash from Investing Activities
-3.1M
N/A
N/A
N/A
-121,579
-88.99%
-1.1M
0.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.3M
N/A
N/A
N/A
-2.7M
-52.61%
-5.7M
0.00%
Financials Ratio
Gross Margin
41.70%
N/A
N/A
N/A
39.42%
-16.60%
47.26%
0.00%
Operating Margin
4.26%
N/A
N/A
N/A
5.20%
-75.01%
20.82%
0.00%
Return on Assets
-7.07%
N/A
N/A
N/A
-5.36%
-39.60%
-8.87%
-5.35%
Return on Equity
-13.31%
N/A
N/A
N/A
-11.72%
-51.35%
-24.10%
-23.20%
Revenue Growth
N/A
N/A
N/A
N/A
-21.71%
N/A
0.00%
+100.00%
Current Ratio
0.94
+74.36%
0.54
+5.79%
0.51
-48.40%
0.99
0.00%
Cash Ratio
0.33
+52.28%
0.22
+27.47%
0.17
-57.14%
0.40
0.00%
Debt-to-Equity Ratio
0.10
+165.95%
0.04
+0.27%
0.04
-55.29%
0.08
N/A
Debt-to-Assets Ratio
0.05
+138.76%
0.02
-1.42%
0.02
-30.72%
0.03
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow